title: Disseminated infection with cutaneous involvement caused by Mycobacterium malmoense in an immunocompromised patient.
authors.affiliation: Department of Dermatology, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
authors.forename: Ramon
authors.initials: R
authors.lastname: Pigem
authors.forename: Mireia
authors.initials: M
authors.lastname: Cairó
authors.forename: Xavier
authors.initials: X
authors.lastname: Martínez-Lacasa
authors.forename: Daniel
authors.initials: D
authors.lastname: Irigoyen
authors.forename: Josep M
authors.initials: JM
authors.lastname: Miró
authors.forename: Juan
authors.initials: J
authors.lastname: Acevedo
authors.forename: Javier
authors.initials: J
authors.lastname: Fernández
authors.forename: Mercè
authors.initials: M
authors.lastname: Alsina-Gibert
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D015658:HIV Infections / Q000175:diagnosis / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D009170:Nontuberculous Mycobacteria / Q000145:classification* / Q000302:isolation & purification; D009894:Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology* / Q000503:physiopathology; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents